NCT02121522 - A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions

Wet Macular Degeneration

Interventions

DRUG

BI 144807

twice daily

Trial Locations (10)

1313.20.43001 Boehringer Ingelheim Investigational Site, Vienna

1313.20.49004 Boehringer Ingelheim Investigational Site, Bonn

1313.20.49002 Boehringer Ingelheim Investigational Site, Leipzig

1313.20.49001 Boehringer Ingelheim Investigational Site, Lübeck

1313.20.49005 Boehringer Ingelheim Investigational Site, Münster

1313.20.49003 Boehringer Ingelheim Investigational Site, Tübingen

1313.20.49006 Boehringer Ingelheim Investigational Site, Ulm

1313.20.36002 Boehringer Ingelheim Investigational Site, Budapest

1313.20.36003 Boehringer Ingelheim Investigational Site, Budapest

1313.20.36001 Boehringer Ingelheim Investigational Site, Debrecen